{"news1": "\u2b50 Axis Bank to buy additional stake : Axis Bank has entered into a revised agreement with Max Financial to buy additional 7% stake in Max Life Insurance. This stake will be bought at fair market value using a discounted cash flow method. Against this backdrop, shares of Max Financial, which is the holding company for Max Life, were up 3.6%.", "news2": "\u2b50 Zydus Lifesciences gets USFDA nod : The pharma company has received final approval from the United States Food and Drug Administration (USFDA) to market Febuxostat Tablets (40 mg and 80 mg). These tablets are used for controlling high uric acid levels in patients. Febuxostat tablets had annual sales (September 2022) of $32 million in the United States.", "news3": "\u2b50 Cyient DLM files for \u20b9740 crore-IPO : The electronic manufacturing services and solutions provider has filed its draft papers with market regulator SEBI to raise \u20b9740 crore through the IPO route. The money raised through the fresh issue will be used for capital working requirements and expenditure."}